Coronavirus: Merck files for U.S. approval of its Covid pill
Sylvie Claire / October 11, 2021
The American laboratory Merck announced on Monday that it had filed an application for authorization with the American authorities for its pill against Covid-19, which could constitute a major advance in the fight against the pandemic.
The application is for Merck's drug molnupiravir for the treatment of adult patients with mild to moderate forms of Covid-19 who are at risk of progressing to severe forms and/or hospitalization, the company said in a statement.
Related Posts
Vaccination for 5- to 11-year-olds: Italy gives green light to Pfizer vaccine
Sylvie Claire / December 2, 2021
Children aged 5 to 11 years will be able to receive one third of the dose given to...
Read More
Omicron variant poses very high risk globally, says WHO
Sylvie Claire / November 29, 2021
The new Omicron variant of the coronavirus presents a very high risk at the global...
Read More
Coronavirus - Omicron: patients are not seriously ill for the moment
Sylvie Claire / November 28, 2021
People infected in South Africa with the new variant of the Omicron coronavirus ar...
Read More